Stockreport

BNTX to Boost Oncology Pipeline With Biotheus Acquisition, Stock Up [Yahoo! Finance]

Instil Bio, Inc.  (TIL) 
NASDAQ:AMEX Investor Relations: nasdaq.com/symbol/til
PDF With the acquisition, BNTX will gain full global rights to BNT327/PM8002, an investigational bispecific antibody targeting PD-L1 and VEGF-A, which is currently being de [Read more]